Trump Admin Advances Plan to Allow Compounding Pharmacies to Produce Peptides
The Trump administration submits an interim access policy for unproven peptides to the White House, bypassing standard FDA safety reviews.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
First reported by MedPageToday.com - medical news for physicians, 30 min ahead of the next publisher · who breaks stories first
This story has stopped developing; this page is its permanent record. More from that day
The odds
Each tick is a source publishing on this story
Price data
| Time | Chance of yes |
|---|---|
| now | 1% |
| 1 Nov, 00:00 UTC | 1% |
| 31 Oct, 23:53 UTC | 2% |
| 31 Oct, 23:11 UTC | 2% |
| 31 Oct, 21:17 UTC | 1% |
| 31 Oct, 20:14 UTC | 2% |
| 31 Oct, 19:59 UTC | 1% |
| 31 Oct, 19:17 UTC | 2% |
| 31 Oct, 17:49 UTC | 2% |
| 31 Oct, 17:21 UTC | 2% |
| 31 Oct, 16:58 UTC | 4% |
| 31 Oct, 03:01 UTC | 1% |
| 30 Oct, 22:33 UTC | 2% |
| 30 Oct, 22:26 UTC | 1% |
| 30 Oct, 20:44 UTC | 2% |
| 30 Oct, 20:08 UTC | 1% |
| 30 Oct, 19:20 UTC | 2% |
| 30 Oct, 18:51 UTC | 1% |
| 30 Oct, 14:07 UTC | 2% |
| 30 Oct, 06:14 UTC | 5% |
| 30 Oct, 04:36 UTC | 4% |
| 30 Oct, 02:48 UTC | 3% |
| 30 Oct, 01:21 UTC | 4% |
| 29 Oct, 23:33 UTC | 5% |
| 29 Oct, 19:36 UTC | 2% |
| 29 Oct, 16:07 UTC | 3% |
| 29 Oct, 15:53 UTC | 6% |
| 29 Oct, 13:38 UTC | 5% |
| 29 Oct, 11:39 UTC | 7% |
| 29 Oct, 04:42 UTC | 5% |
| 29 Oct, 03:35 UTC | 6% |
| 28 Oct, 21:06 UTC | 9% |
| 28 Oct, 05:58 UTC | 6% |
| 27 Oct, 23:45 UTC | 17% |
| 27 Oct, 20:10 UTC | 7% |
| 27 Oct, 15:27 UTC | 8% |
| 27 Oct, 04:06 UTC | 9% |
| 26 Oct, 20:32 UTC | 30% |
| 25 Oct, 20:40 UTC | 7% |
| 25 Oct, 17:10 UTC | 6% |
| 23 Oct, 18:14 UTC | 12% |
| 23 Oct, 03:41 UTC | 11% |
| 22 Oct, 19:58 UTC | 6% |
| 22 Oct, 14:31 UTC | 15% |
| 21 Oct, 16:36 UTC | 11% |
| 20 Oct, 16:49 UTC | 8% |
| 20 Oct, 05:47 UTC | 6% |
| 19 Oct, 02:08 UTC | 8% |
| 19 Oct, 00:58 UTC | 9% |
| 18 Oct, 17:45 UTC | 6% |
| 16 Oct, 18:24 UTC | 16% |
| 16 Oct, 15:24 UTC | 14% |
| 16 Oct, 02:55 UTC | 8% |
| 14 Oct, 20:33 UTC | 14% |
Replay the odds, article by article
Step through each article in the order it published and watch Peptide respond.
The story so far
5 publishers have covered this in 6 articles since 15 Oct 2026. MedPageToday.com - medical news for physicians published first, on 15 October at 20:15 UTC; STAT followed 31 min later. The most recent article, from The New York Times, appeared on 16 October at 18:57 UTC.
Outlets reporting it: The Hill (major outlet), Ars Technica (major outlet), The New York Times (major outlet), MedPageToday.com - medical news for physicians, STAT.
3 prediction markets price this story:
- Peptide — resolved “No” on 1 Nov 2026. The outcome is Yes if Donald Trump states the word Peptide, or a plural or possessive form of it, between October 1, 2026 at 10:00am ET and November 1, 2026 at 12:00am ET. Otherwise, the outcome is No. Readers often mistake the linked news story as sufficient evidence, but only a direct statement by Trump during the specified window counts.
- KPV — the market puts it at 85%, closing 1 Oct 2027. The market resolves to Yes if the U.S. Food and Drug Administration publishes a proposed rule adding KPV (free base) or KPV acetate to the 503A Bulks List before October 1, 2027. Otherwise, it resolves to No. Readers often mistake the linked news story about compounding pharmacies for the official FDA action required for resolution.
- Yes — the market puts it at 5%, closing 3 Nov 2026. The market resolves to Yes if Donald Trump signs an executive action imposing a tariff of at least 100% on imported generic pharmaceutical drugs before November 3, 2026. Otherwise, it resolves to No. Readers often mistake the linked news story about Medicare drug rules for the required tariff action.
Odds are the market's probability that the outcome happens, updated every few minutes. They are information about what traders expect, not a forecast we make and not investment advice.
How it unfolded
Every source in the order it published, with the odds on Peptide at that moment. A dash means the source published before we started tracking prices.
- MedPageToday.com - medical news for physiciansTrump Administration Advances Plan for Peptides Favored by RFK Jr.14%
- STATTrump administration advances plan for peptide drugs favored by RFK Jr.14%
- The HillFDA advances peptide push to White House14%
- STATSTAT+: Pharmalittle: We’re reading about an HHS peptide push, Trump’s pharma stock holdings, and more8%▼6 points since the previous source
- Ars TechnicaRFK Jr. proposes FDA look the other way on unproven peptides, report says14%▲6 points since the previous source
- The New York TimesRFK Jr. Pledged to Advance Anti-Vaccine Group’s Goals. Here’s What He’s Doing.16%▲2 points since the previous source
- Market resolved: No
Sources
Every article we clustered into this story. Headlines link to the publisher.
- RFK Jr. Pledged to Advance Anti-Vaccine Group’s Goals. Here’s What He’s Doing. The New York Times ·
- RFK Jr. proposes FDA look the other way on unproven peptides, report says Ars Technica ·
- FDA advances peptide push to White House The Hill ·
- STAT+: Pharmalittle: We’re reading about an HHS peptide push, Trump’s pharma stock holdings, and more STAT
- Trump administration advances plan for peptide drugs favored by RFK Jr. STAT
- Trump Administration Advances Plan for Peptides Favored by RFK Jr. MedPageToday.com - medical news for physicians
Related prediction markets
Linked by software because they are about the same subject. Most ask a different question from the one this story reports, so read each market's own question. How often the link is right
- Resolved Peptide No 6d ago
The market favoured No at 99% a day out, and it won. How often it's right
Wrong market?
- Kalshi KPV 85%
Does the market have this right?
Wrong market?
- Kalshi Yes 5%
Does the market have this right?
Wrong market?
Have your say
Your call. How does this end?
Free, no money involved. Calls are scored against the market's price when you make them, so backing an underdog that wins scores most. Leaderboard · Your calls
In this story
- Robert F. Kennedy Jr.
- FDA
- Trump administration